Trump Medicare Drug Pricing

Order byBest matchMost fresh

Trump, drug prices

Trump signs executive order to reduce drug prices: What we know

President Donald Trump signed an executive order on May 12 directing drugmakers to lower the prices of their medicines so they line up with what other countries pay.

· 2d

· 2d · on MSN

Pharmaceutical industry criticizes the drug pricing plan Trump says he'll sign

· 1d

Trump ordering U.S. to pay only the price other nations do for some drugs

Trump mentions ‘fat shot drug’ in executive order announcement. Will Ozempic get cheaper?

Trump signed an executive order on May 12 aimed at lowering drug prices to better match what other countries charge.

· 1d

Wall Street shrugs at Trump’s most-favored order

· 19h

GOP targets Medicaid: Trump admin’s Dr. Oz on drugs & getting vaccinated despite RFK Jr. claims

Big pharma’s jumbo profits are under threat in America

Rather than cutting prices there, many firms would raise them abroad and perhaps pull out of some countries altogether, meaning Mr Trump’s policy would shrink their businesses while doing little to lo...

The Economist · 1d

· 1d

Dow and S&P 500 rally following truce in the US-China trade war. Here’s how it unfolded.

· 1d

What has Trump said about cutting drug prices?

4hon MSN

Trump wants to cut out ‘middleman’ as part of drug pricing order: What are pharmacy benefit managers?

President Donald Trump's new health care initiative aims to reduce prescription drug costs by targeting pharmacy benefit managers, commonly known as PBMs.

5don MSN

Trump to unveil Medicare drug pricing plan after teasing "earth-shattering" announcement

President Trump will introduce a "most favored nation" plan aimed at cutting Medicare drug prices by linking them to the prices of medication abroad, sources told CBS News.

1don MSN

Trump drug pricing proposal puts GOP senators in a tough spot

An executive order from President Trump aims to make deep cuts to prescription drug costs, putting GOP lawmakers who have traditionally opposed government-directed drug pricing in a tough position.